Delivery Order SPE2DB20D1100-SPE2DB24FA7E9
Award Date
3/13/24
Potential Completion Date
3/14/24
Potential Value
$9.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $19,118.40 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This is a $6,359.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RUXIENCE 500 mg/50 ml vials and has an ultimate completion date of January 16, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for providing a...
This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,418.70 firm fixed price order is for the supply of RUXIENCE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. This delivery order does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 IDC with DLA Troop Support Medical to...
This is a $53,734.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of September 10, 2024 and is not set aside for any specific business type. AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999, to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, with a potential value of $3,135.11, is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a specialty pharmaceutical product, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $6,030.76 award is for the supply of Ruxience 500 mg/50 ml vial, a specialty pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen Drug Corp to provide pharmaceuticals and medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RUXIENCE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $14,387.84 and an ultimate completion date of July 23, 2024. The contract type is Firm Fixed Price. There is no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor. This delivery order is likely part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, at a ceiling value of $5,141.74. The contract is a firm fixed price delivery order with a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,441.36, is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a medical product, to support federal healthcare programs. The contract has an ultimate completion date of January 29, 2025. This award is part of AmerisourceBergen's larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML medication. The contract has a ceiling value of $9,457.40 and a period of performance through August 1, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of...